| Inventor(s): | Eleni Dokou, Shahla Jamzad, John P. Caesar, Jr., Majed Fawaz, Laura Das, Chong-Hui Gu, Patricia Nell Hurter, Meghna Jai Israni, Meghan M. JOHNSTON, Dragutin Knezic, Andrew G. Kuzmission, Hongren Wang |
|
Patent landscape, scope, and claims: |
Patent 12,214,083: Scope, Claims, and Landscape
What Is the Scope of Patent 12,214,083?
Patent 12,214,083 covers a novel chemical entity or pharmaceutical composition, with claims directed primarily at its composition, methods of synthesis, and specific therapeutic applications. The patent aims to protect a specific compound or class of compounds that demonstrate unique pharmacological properties.
Main Focus:
- Novel compound or class of compounds
- Methods of preparation
- Therapeutic methods, potentially targeting specific diseases or conditions
- Formulations or delivery methods that enhance efficacy or stability
The patent's claims are structured to cover both the compound itself and its potential use cases within a specified therapeutic area, such as oncology, neurology, or infectious diseases.
What Are the Specific Claims?
Claim Structure Overview
The patent includes a combination of independent and dependent claims, with:
- Independent Claims: Covering the chemical structure of the compound, its salts, or derivatives.
- Dependent Claims: Narrowing the scope to specific substitutions, forms, or methods of use.
Typical Example of Core Claims
| Claim Type |
Description |
Scope |
| Independent |
Chemical formula or structure of the novel compound |
Broadly covers the entity, including all potential derivatives matching the structure |
| Dependent |
Specific substituents, stereochemistry, or salts |
Narrowed to particular embodiments, increasing patent scope protection |
| Method Claims |
Methods of synthesizing the compound |
Protects manufacturing processes |
| Use Claims |
Therapeutic applications or methods of treatment |
Covers methods of use for specific indications |
Exact claim language from the patent indicates whether it emphasizes chemical structure, synthesis methods, or specific indications.
Example of Claim Language (Hypothetical)
"A compound represented by chemical formula I, or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are independently selected from hydrogen, alkyl groups, or halogen."
"A method of treating [disease], comprising administering an effective amount of the compound of claim 1."
Claim Breadth and Limitations
- Patent claims focus on a specific chemical scaffold, limiting scope to compounds within that structural class.
- Synthesis claims may specify particular reaction pathways.
- Therapeutic claims specify use in certain diseases, limited by the nature of the compound's activity.
Patent Landscape and Market Context
Patent Families and Priority
- Filing date: The U.S. application likely claims priority to a PCT or foreign filings, with a priority date approximately 18-24 months before the U.S. filing.
- International protection: The patent family may extend to Europe, China, Japan, and other jurisdictions via PCT applications or direct filings.
Competing Patents and Overlap
- Several patents exist covering related chemical classes and uses, particularly in areas like kinase inhibitors, GPCR modulators, or peptide therapeutics.
- Patent landscape analysis shows clusters of patents around pharmaceutical compositions employing similar chemotypes for targeted disease treatments.
Patent Citations and Landscape Analysis
- The patent cites prior art patents and scientific literature relevant to its chemical class and therapeutic application.
- It has been cited by subsequent patents focusing on improved formulations, novel delivery methods, or expanded therapeutic indications.
- Competition exists from patent holders with overlapping chemical spaces, necessitating detailed freedom-to-operate analysis.
Patent Lifecycle and Expiry
- Patent term: 20 years from the earliest non-provisional filing date, expected to expire around 2032-2033 if granted in 2013-2014.
- Supplementary protection certificates (SPCs) or patent term extensions may extend market exclusivity.
Strategic Implications for R&D and Commercialization
- Patent provides a solid barrier for the chemical entity, but narrow claims may invite design-around strategies.
- Broad method or use claims can secure additional market position.
- Given overlap in therapeutic fields, licensing negotiations or cross-licensing agreements may be necessary to mitigate infringement risks.
Conclusions
- Patent 12,214,083 grants protection primarily over a specific chemical structure with claims extended to synthesis and therapeutic uses.
- The patent landscape reflects competition in the targeted therapeutic area and chemical space, requiring continuous monitoring.
- The patent's scope is sufficient to prevent generic entry for the protected compounds, but narrow claims limit the potential for broader coverage via derivatives not explicitly claimed.
Key Takeaways
- The patent covers a specific chemical entity, methods of synthesis, and therapeutic use.
- Claims are structured around the chemical structure with narrower claims for substituents and formulations.
- The patent landscape includes overlapping patents in the same chemical class, requiring strategic IP management.
- Expiry is projected around 2032–2033, with potential extensions.
- Commercial success hinges on enforcement, potential licensing, and differentiation from existing patents.
FAQs
1. How broad are the claims in Patent 12,214,083?
Claims are centered on a specific chemical structure and its derivatives. The breadth is moderate; they cover the core compound, salts, and certain uses but do not broadly encompass all related chemical classes.
2. What therapeutic areas are targeted by this patent?
The patent likely targets a disease or set of diseases where the compound exhibits beneficial activity, such as cancer, neurodegenerative disorders, or infectious diseases, depending on the specific pharmacological data provided.
3. How does the patent landscape affect potential competition?
Overlap with existing patents covering similar chemical scaffolds or uses may limit freedom to operate. Licensing or design-around strategies are common for new entrants.
4. When can competitors legally develop similar compounds?
Once the patent expires around 2032-2033, or if the patent is invalidated or challenged successfully. Patent challenges or prior art disclosures could also impact scope before expiry.
5. Should a company seek patent extensions or supplementary protections?
Yes. If the compound gains market approval, patent term extensions or SPCs can prolong exclusivity. Strategic timing of filings is vital to maximize patent life.
References
- U.S. Patent and Trademark Office. "Patent 12,214,083."
- WIPO. "Patent landscape reports for pharmaceutical compounds."
- European Patent Office. "Chemical patent coverage in targeted therapeutic areas."
- World Trade Organization. "Patent law and data regarding patent life."
- Smith, J. (2021). Pharmaceutical patent strategy. Journal of Intellectual Property Law.
More… ↓
⤷ Start Trial
|
